"Final Stage Trial of Gates-Backed TB Vaccine Underway in South Africa"
TL;DR Summary
The Bill & Melinda Gates Medical Research Institute has launched a Phase III trial in South Africa to test an experimental tuberculosis vaccine's ability to prevent latent infections from developing into potentially deadly lung disease. The study, with an estimated cost of $550 million, is being funded by the Wellcome Trust and the Gates Foundation.
Topics:health#bill-and-melinda-gates-foundation#health-and-medicine#phase-iii-trial#south-africa#tuberculosis#vaccine
- Gates-backed PhIII study tuberculosis vaccine study gets underway Endpoints News
- TB shot is in final stage of testing POLITICO
- Phase 3 trial for TB vaccine candidate launches in South Africa University of Minnesota Twin Cities
- Tuberculosis Vaccine Candidate Launches Substantive Phase 3 Study — Precision Vaccinations News Precision Vaccinations
- Bill & Melinda Gates Medical Research Institute initiates Ph 3 trial of TB vaccine candidate BSA bureau
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
0 min
vs 1 min read
Condensed
53%
116 → 55 words
Want the full story? Read the original article
Read on Endpoints News